This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/507670-moderna-coronavirus-vaccine-eu/
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
Version 0 | Version 1 |
---|---|
Moderna to supply 160 million doses of its Covid-19 vaccine to EU | Moderna to supply 160 million doses of its Covid-19 vaccine to EU |
(about 2 hours later) | |
US biotech firm Moderna will become the sixth company to supply a coronavirus vaccine candidate to the EU after European Commission President Ursula von der Leyen said a deal for 160 million doses has been reached. | US biotech firm Moderna will become the sixth company to supply a coronavirus vaccine candidate to the EU after European Commission President Ursula von der Leyen said a deal for 160 million doses has been reached. |
"I am happy to announce that tomorrow we will approve a new contract to secure another Covid-19 vaccine," von der Leyen said on Tuesday. | "I am happy to announce that tomorrow we will approve a new contract to secure another Covid-19 vaccine," von der Leyen said on Tuesday. |
The deal will allow the EU to buy up to 160 million doses of the vaccine developed by Moderna. | The deal will allow the EU to buy up to 160 million doses of the vaccine developed by Moderna. |
Last week, the American company announced that its vaccine has shown 94.5 percent effectiveness in preventing Covid-19, according to the results of interim late-stage clinical trials. | Last week, the American company announced that its vaccine has shown 94.5 percent effectiveness in preventing Covid-19, according to the results of interim late-stage clinical trials. |
Moderna's drug is the six vaccine for which the bloc has reached a deal. Brussels earlier signed contracts with three EU-based biotech firms and the UK's AstraZeneca, while also purchasing vaccine jointly develop by Germany’s BioNtech and Pfizer of the US. | |
Brussels said that such a diversified portfolio will ensure that the EU is well-prepared for vaccination from Covid-19, once the candidate vaccines have been proven to be safe and effective. | Brussels said that such a diversified portfolio will ensure that the EU is well-prepared for vaccination from Covid-19, once the candidate vaccines have been proven to be safe and effective. |
Russia's Sputnik V, which became the world's first registered vaccine in August, may also be used in the EU as member state Hungary received its first samples of it last week. | Russia's Sputnik V, which became the world's first registered vaccine in August, may also be used in the EU as member state Hungary received its first samples of it last week. |
Budapest insists that it's going to perform clinical trials of the Russian vaccine, despite opposition from Brussels, which says that foreign vaccines – not certified within the bloc – are a no-go. | Budapest insists that it's going to perform clinical trials of the Russian vaccine, despite opposition from Brussels, which says that foreign vaccines – not certified within the bloc – are a no-go. |
On Tuesday, the team behind Sputnik V said that their vaccine was at least 95 percent effective, exceeding previous expectations. The result was based on data from Phase III trials, which involved almost 20,000 volunteers. | On Tuesday, the team behind Sputnik V said that their vaccine was at least 95 percent effective, exceeding previous expectations. The result was based on data from Phase III trials, which involved almost 20,000 volunteers. |
Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
Previous version
1
Next version